Kiniksa Pharmaceuticals International, Plc · NASDAQ:KNSA
Ragosa Mark exercised options for 2,694 Kiniksa Pharmaceuticals International, Plc shares (Form 4)
Traded Apr 7, 2026 · Filed Apr 8, 2026
On Apr 7, 2026, Ragosa Mark (CHIEF FINANCIAL OFFICER) exercised options for 2,694 Kiniksa Pharmaceuticals International, Plc shares, leaving 16,154 shares. Filed Apr 8, 2026 (Form 4).
- Options exercised
- 2,694 shares
- Holding after
- 16,154 shares
- Trading plan
- No
- Role
- CHIEF FINANCIAL OFFICER
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Apr 7, 2026 | Class A Ordinary Share | Option exercise | 2,694 | 17,457 | Direct | |
| Apr 7, 2026 | Class A Ordinary Share | Shares withheld for tax | 1,303 | US$48.94 | 16,154 | Direct |
Source
Related
- Kiniksa Pharmaceuticals International, Plc
- Ragosa Mark
- Kiniksa Pharmaceuticals International, Plc shareholders
- Form 4 · Ragosa Mark · Sep 3, 2026
- Form 4 · Ragosa Mark · Apr 3, 2026
- Form 4 · Megna Michael R · Sep 3, 2026
- Form 4 · Paolini John F. · Sep 3, 2026
- Form 4 · Patel Sanj K · Sep 3, 2026
- Form 4 · Moat Ross · Sep 3, 2026
- Form 4 · Quart Barry D · Aug 21, 2026